All these results together indicate that CHEK1-hsa-mir-195-5p/hsa-mir-497-5p and GPSM2-hsa-mir-122-5p may be key pathways in mediating progression of hepatocellular carcinoma and that link to patients' prognosis. This evidence concerns the gene GPSM2 and hepatocellular carcinoma.